0.60
-0.0999(-14.27%)
Currency In USD
Address
83 Clemenceau Avenue
Singapore, 239920
Singapore
Phone
65 6222 4235
Website
Sector
Healthcare
Industry
Biotechnology
Employees
35
First IPO Date
May 04, 2018
| Name | Title | Pay | Year Born |
| Dr. Carl Alan Jason Morton Firth EMBA, Ph.D. | Founder, Chief Executive Officer & Executive Director | 0 | 1973 |
| Chi-Chin Wang | IR & Corporate Development Director | 0 | N/A |
| Mr. Ben Goodger | General Counsel | 0 | 1963 |
| Mr. Stephen Doyle | Chief Business Officer | 0 | 1973 |
| Mr. Kiran Kumar Asarpota | Chief Operating Officer & Head of Finance | 0 | 1979 |
| Dr. Alexandre Kaoukhov M.D. | Chief Medical Officer | 0 | 1974 |
| Charlie Hsu | Investor Relations Director | 0 | N/A |
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.